143 related articles for article (PubMed ID: 26301462)
1. Pharmacological Evidence that Histamine H3 Receptors Mediate Histamine-Induced Inhibition of the Vagal Bradycardic Out-flow in Pithed Rats.
García M; García-Pedraza JÁ; Villalón CM; Morán A
Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):113-21. PubMed ID: 26301462
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evidence that histamine H3 receptors inhibit the vasodepressor responses by selective stimulation of the rat perivascular sensory CGRPergic outflow.
Manrique-Maldonado G; Altamirano-Espinoza AH; Marichal-Cancino BA; Rivera-Mancilla E; Avilés-Rosas V; Villalón CM
Eur J Pharmacol; 2015 May; 754():25-31. PubMed ID: 25704614
[TBL] [Abstract][Full Text] [Related]
3. Further evidence for the role of histamine H3, but not H1, H2 or H4, receptors in immepip-induced inhibition of the rat cardioaccelerator sympathetic outflow.
Pinacho-García M; Marichal-Cancino BA; Villalón CM
Eur J Pharmacol; 2016 Feb; 773():85-92. PubMed ID: 26826593
[TBL] [Abstract][Full Text] [Related]
4. The role of pre-junctional D2 -like receptors mediating quinpirole-induced inhibition of the vasodepressor sensory CGRPergic out-flow in pithed rats.
Manrique-Maldonado G; González-Hernández A; Altamirano-Espinoza AH; Marichal-Cancino BA; Ruiz-Salinas I; Villalón CM
Basic Clin Pharmacol Toxicol; 2014 Feb; 114(2):174-80. PubMed ID: 23964609
[TBL] [Abstract][Full Text] [Related]
5. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory H3 receptors on sympathetic nerves of the pithed rat: activation by endogenous histamine and operation in spontaneously hypertensive rats.
Godlewski G; Malinowska B; Buczko W; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):261-6. PubMed ID: 9050021
[TBL] [Abstract][Full Text] [Related]
7. Chronic Sarpogrelate Treatment Reveals 5-HT7 Receptor in the Serotonergic Inhibition of the Rat Vagal Bradycardia.
García-Pedraza JÁ; García M; Martín ML; Eleno N; Morán A
J Cardiovasc Pharmacol; 2017 Jan; 69(1):13-22. PubMed ID: 27676327
[TBL] [Abstract][Full Text] [Related]
8. Activation of 5-HT1B receptors inhibits the vasodepressor sensory CGRPergic outflow in pithed rats.
González-Hernández A; Muñoz-Islas E; Lozano-Cuenca J; Ramírez-Rosas MB; Sánchez-López A; Centurión D; Ramírez-San Juan E; Villalón CM
Eur J Pharmacol; 2010 Jul; 637(1-3):131-7. PubMed ID: 20385119
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine oral treatment discloses 5-HT
López C; Gómez-Roso M; García-Pedraza JÁ; Martín ML; Morán A; García-Domingo M
Can J Physiol Pharmacol; 2019 Feb; 97(2):90-98. PubMed ID: 30462556
[TBL] [Abstract][Full Text] [Related]
10. Differential cardiac sympatho-inhibitory responses produced by the agonists B-HT 933, quinpirole and immepip in normoglycaemic and diabetic pithed rats.
Rivera-Mancilla E; Altamirano-Espinoza AH; Manrique-Maldonado G; Villanueva-Castillo B; Villalón CM
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):767-778. PubMed ID: 29675928
[TBL] [Abstract][Full Text] [Related]
11. Role of pre-junctional CB1, but not CB2 , TRPV1 or GPR55 receptors in anandamide-induced inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats.
Marichal-Cancino BA; Altamirano-Espinoza AH; Manrique-Maldonado G; MaassenVanDenBrink A; Villalón CM
Basic Clin Pharmacol Toxicol; 2014 Mar; 114(3):240-7. PubMed ID: 24118786
[TBL] [Abstract][Full Text] [Related]
12. The dopamine receptors mediating inhibition of the sympathetic vasopressor outflow in pithed rats: pharmacological correlation with the D(2) -like type.
Manrique-Maldonado G; González-Hernández A; Marichal-Cancino BA; Villamil-Hernández MT; del Mercado OA; Centurión D; Villalón CM
Basic Clin Pharmacol Toxicol; 2011 Dec; 109(6):506-12. PubMed ID: 21740529
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological analysis of the inhibition produced by moxonidine and agmatine on the vasodepressor sensory CGRPergic outflow in pithed rats.
Rubio-Beltrán E; Labastida-Ramírez A; Hernández-Abreu O; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2017 Oct; 812():97-103. PubMed ID: 28694067
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D
García-Pedraza JÁ; Morán A; Martín ML; Ollauri-Ibáñez C; Rodríguez-Barbero A; Villalón CM; García-Domingo M
Pflugers Arch; 2020 Dec; 472(12):1693-1703. PubMed ID: 32820344
[TBL] [Abstract][Full Text] [Related]
15. Dihydroergotamine inhibits the vasodepressor sensory CGRPergic outflow by prejunctional activation of α
González-Hernández A; Lozano-Cuenca J; Marichal-Cancino BA; MaassenVanDenBrink A; Villalón CM
J Headache Pain; 2018 May; 19(1):40. PubMed ID: 29802544
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
[TBL] [Abstract][Full Text] [Related]
17. The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.
González-Hernández A; Manrique-Maldonado G; Lozano-Cuenca J; Muñoz-Islas E; Centurión D; Maassen VanDenBrink A; Villalón CM
Eur J Pharmacol; 2011 Jun; 659(2-3):233-43. PubMed ID: 21473863
[TBL] [Abstract][Full Text] [Related]
18. Olcegepant blocks neurogenic and non-neurogenic CGRPergic vasodepressor responses and facilitates noradrenergic vasopressor responses in pithed rats.
Avilés-Rosas VH; Rivera-Mancilla E; Marichal-Cancino BA; Manrique-Maldonado G; Altamirano-Espinoza AH; Maassen Van Den Brink A; Villalón CM
Br J Pharmacol; 2017 Jul; 174(13):2001-2014. PubMed ID: 28369749
[TBL] [Abstract][Full Text] [Related]
19. Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats.
Sadek B; Saad A; Subramanian D; Shafiullah M; Łażewska D; Kieć-Kononowiczc K
Neuropharmacology; 2016 Jul; 106():46-55. PubMed ID: 26525191
[TBL] [Abstract][Full Text] [Related]
20. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
